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The FHH (fawn-hooded hypertensive) rat is a model of
hypertension-associated chronic kidney damage. Five
interacting quantitative trait loci (QTLs), named Rf-1–Rf-5,
determine the high renal susceptibility. The aim of the
present study was to investigate a possible interaction
between Rf-1 and Rf-3. Differences in renal susceptibility
between ACI (AugustCopenhagen Irish) controls, Rf-1A and
Rf-3 single congenics, and Rf-1Aþ 3 double congenic rats
were assessed using four different treatments: two-kidney
control (2K), 2K plus Nx-nitro-L-arginine methyl ester
(L-NAME)-induced hypertension (2Kþ L-NAME), unilateral
nephrectomy (UNX), and UNX plus L-NAME-induced
hypertension (UNXþ L-NAME). Proteinuria (UPV) and systolic
blood pressure (SBP) were assessed after 6, 12, and 18 weeks,
while the incidence of glomerulosclerosis (%FGS) was
determined at the end of the experiment. In a separate
experiment, renal autoregulation was assessed in 13–15-week
old 2K rats of all four strains. Compared to ACI rats, small
increases in renal susceptibility were found in Rf-1A and
Rf-3 single congenics following 2Kþ L-NAME, UNX, and
UNXþ L-NAME treatments. However, in the Rf-1Aþ 3 double
congenics, a major increase in renal susceptibility was found
with all four treatments. Both Rf-1A and Rf-1Aþ 3 congenic
rats had an impaired renal autoregulation. In contrast, the
Rf-3 had a normal autoregulation, similar to that of the ACI
rat. These findings indicate that Rf-1 and Rf-3 alone slightly
increase the susceptibility to the development of renal
damage. However, a synergistic interaction between these
two QTLs markedly enhances renal susceptibility. In contrast
to the Rf-1 region, the Rf-3 region does not carry genes
influencing renal autoregulation.
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Chronic kidney disease (CKD) is an important risk factor for
the progression to end-stage renal failure (ESRF), cardio-
vascular disease, and overall mortality.1–3 A large majority of
CKD and ESRF is not associated with primary renal disease,
but with systemic conditions like diabetes and hypertension.4
However, only a minority of patients with diabetes and/or
hypertension develops CKD, indicating that other aspects,
such as genetic factors, also determine susceptibility to
progressive renal disease.5 Finding genes involved in these
complex forms of nephropathy in humans has not been very
successful.6–8 Studies with inbred rat strains, also varying
widely in their susceptibility to develop renal damage, may be
helpful to elucidate the pathophysiology and genetics of
progressive nephropathy.
Studies with crosses of the FHH (fawn-hooded hyper-
tensive) rat, a well-characterized model of hyperten-
sion-associated proteinuria (UPV) and ESRF,9–15 and the
renal-resistant ACI (AugustCopenhagen Irish) rat revealed
the presence of five quantitative trait loci (QTLs), named
renal-failure-1 (Rf-1) to Rf-5, linked to UPV and other
parameters of renal damage.16,17 These QTLs are thought to
contain gene(s) influencing the susceptibility to progressive
renal damage in the FHH rat. Although the nature of the
genes is still unknown, the role of each QTL can be studied in
congenic rat strains that have an Rf-region of the FHH rat
introgressed in the genomic background of the renal-resistant
ACI rat. Next, interactions between QTLs can be studies in
double and multiple congenic strains. The ACI strain is
resistant to develop marked UPV even when made hyper-
tensive by No-nitro-L-arginine methyl ester (L-NAME)
treatment or following unilateral nephrectomy (UNX).
Therefore, we need to induce hypertension and/or renal
mass reduction to initiate progressive renal damage permit-
ting to study the effect of introgressing a single QTL from the
FHH rat into the ACI genomic background. Previously, we
http://www.kidney-international.org o r i g i n a l a r t i c l e
& 2006 International Society of Nephrology
Received 18 October 2005; revised 20 December 2005; accepted 3
January 2006; published online 15 March 2006
Correspondence: AP Provoost, Department of Paediatric Surgery, Erasmus
MC, Room Wk 207, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
E mail: a.provoost@erasmusmc.nl
Kidney International (2006) 69, 1369–1376 1369
reported about the susceptibility to renal damage in strains of
ACI.FHH-Rf1 (Rf-1 for short), ACI.FHH-Rf4 (Rf-4), and
ACI.FHH-Rf5 (Rf-5) single congenics.18–20 Following UNX
combined with L-NAME-induced hypertension, Rf-1
congenic rats developed significantly more UPV and
albuminuria than the ACI parental strain. In contrast, the
Rf-4 and Rf-5 single congenic rats showed no significant
increase in renal susceptibility. Interestingly, in Rf-1 congenic
rats, renal blood flow (RBF) autoregulation was impaired to
the same extent as the parental FHH rat, while a normal
renal autoregulation was present in Rf-4 and Rf-5 single
congenics.14,19,20
Despite the absence of a direct effect of the Rf-4 QTL on
renal susceptibility, the combined presence of the Rf-1 and
Rf-4 QTLs markedly increased renal damage susceptibility.20
The magnitude of the interaction depended on the experi-
mental treatment. It was small in the normotensive two-
kidney (2K) situation, intermediate following L-NAME
treatment in 2K rats and in normotensive rats following
UNX. The largest interaction was noted in the L-NAME-
treated UNX rats.20 These experiments provided direct
evidence for an interaction between the Rf-1 and Rf-4 QTLs,
already suggested by the linkage analysis.17
In the present experiments, we tested the presence of an
interaction between the Rf-1 and Rf-3 QTLs. Therefore, we
compared the renal susceptibility between the ACI parental
strain and three congenic strains, that is, Rf-1A and Rf-3
single congenics and Rf-1Aþ 3 double congenics, in four
experimental situations. Similar to the combination of Rf-1
and Rf-4, we found evidence for a significant synergistic
interaction between the Rf-1 and Rf-3 QTLs increasing the
susceptibility to renal damage. Again, the magnitude of the
interaction depended on the experimental treatment. In
addition, we found that renal autoregulation was impaired in
Rf-1A single and Rf-1Aþ 3 double congenic rats. In contrast,
renal autoregulation in Rf-3 single congenics was similar to
that of ACI rats.
RESULTS
Animal survival and UPV
All 2K, 2Kþ L-NAME, and UNX rats survived the 18-week
follow-up period. Following UNXþ L-NAME treatment, two
of the 12 Rf-1Aþ 3 double congenic rats did not survive up
to the second measurement, and another two of the
remaining 10 Rf-1Aþ 3 double congenics did not survive
up to the third measurement. In addition, three UNXþ L-
NAME-treated Rf-1Aþ 3 double congenic rats did not eat at
the third measurement, leaving only five rats to be evaluated.
Data obtained from the rats that died prematurely or did not
eat are included in the results for the first and second
measurements (Figure 1).
Mean values for UPV during follow-up from the various
treatments are presented in Figure 2. In all four experimental
situations, relatively small differences in UPV were noted
between ACI and the Rf-1 or Rf-3 single congenic rats. In the
2K situation, Rf-3 congenics show an increased UPV
compared to ACI at the second measurement. At the final
measurement following L-NAME treatment in 2K rats, a
slight albeit not significant increase in UPV was found in
Rf-1A and Rf-3 single congenics compared to ACI. Following
UNX, Rf-1A single congenics showed an increase in UPV at
the third time point compared to ACI and Rf-3 congenic rats.
After UNXþ L-NAME treatment, Rf-1A and Rf-3 single
congenics have a significantly higher UPV compared to ACI
at the third time point.
In contrast to the small effects in the single congenic
strains, a large effect on UPV was observed in Rf-1Aþ 3
double congenic rats. Compared to ACI, Rf-1A, and Rf-3
single congenic rats, the UPV levels were significantly higher
in the double congenics at all time points and with all four
treatments.
Systolic blood pressure
Mean values for systolic blood pressure (SBP) are presented
in Figure 3. In the 2K situation and following UNX, all
strains remained normotensive and only slight differences in
SBP were noted between the four strains. At the first
measurement, the SBP of the congenic strains was slightly,
but significantly, higher compared to ACI. However, the
differences were no longer present at the second and third
measurements. After UNX, a slightly higher SBP was present
in the Rf-1Aþ 3 double congenics compared to the Rf-1A
and Rf-3 single congenic rats at the third time point. In the 2
K situation, chronic L-NAME treatment increased SBP in all
strains. At the first time point, SBP in all congenic strains was
significantly increased compared to ACI rats. At the second
and third time point, the Rf-1Aþ 3 double congenic rats had
a significantly higher SBP compared to ACI, Rf-1A, and Rf-3
single congenic rats. Following UNXþ L-NAME treatment,
the Rf-1Aþ 3 double congenic rats had a significantly higher
SBP compared to the other strains at the first and second
time point.
Interactions between the Rf-1 and Rf-3 QTLs
The results of the 2 2 factorial analysis of variance
(ANOVA) analyses showed the presence of significant
interactions between Rf-1 and Rf-3. The Rf-1 and Rf-3 QTLs
each showed to have an effect on UPV compared to ACI.
Combining Rf-3 with Rf-1A always resulted in a further
increase in UPV when compared to Rf-1A and Rf-3 single
congenics. Furthermore, the magnitude of these interactions
was significant in all three experimental situations. The
synergistic effect was relatively small in the 2K situation. The
magnitude of the effect markedly increased in the 2Kþ L-
NAME-, UNX-, and UNXþ L-NAME-treated rats, that is,
with an increase in the hemodynamic stress upon the kidney
(Table 1).
An example is presented in Figure 4, for UPV at the
second time point, after 12 weeks of treatment at the age of
about 18 weeks. It is shown that changing the genotype on
chromosome 3 (Rf-3) from homozygous ACI (AA) to
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Figure 1 | Genetic maps of rat chromosomes 1 and 3 depicting the homozygous FHH regions introgressed on the ACI background in
the Rf-1A, Rf-3 single, and Rf-1Aþ 3 double congenic strains. On the left-hand side of the chromosomes, the areas of homozygous FHH in
the various congenic strains are indicated by the solid and striped lines. The arrows on the right-hand side of the chromosomes indicate the
locations of the Rf-1 and Rf-3 QTL peaks found in previous studies, that is, D1Mgh12 for Rf-1, and D3Mit4 for Rf-3.16,17 Distances are given in Mb,
95% CI represents the 95% confidence interval of the quantitative trait loci (QTLs).
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Figure 2 | UPV after 6, 12, and 18 weeks of follow-up in ACI (B),
Rf-1A (’), Rf-3 ( ), and Rf-1Aþ 3 ( ) rats. (a) Two-kidney. (b) Two-
kidneyþ L-NAME-induced hypertension. (c) Unilateral nephrectomy.
(d) Unilateral nephrectomyþ L-NAME-induced hypertension. Values
(mg/day/100 g BW) are given as mean7s.e.m. for 12 rats at each
point unless stated otherwise. *Po0.05 compared to ACI, Rf-1A, and
Rf-3; 1Po0.05 compared to ACI and Rf-3; #Po0.05 compared to ACI
and Rf-1A.
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Figure 3 | Tail cuff SBP after 6, 12, and 18 weeks of follow-up
in ACI (B), Rf-1A (’), Rf-3 ( ), and Rf-1Aþ 3 ( ) rats. (a) 2K.
(b) 2Kþ L-NAME-induced hypertension. (c) Unilateral nephrectomy.
(d) Unilateral nephrectomyþ L-NAME-induced hypertension. Values
(mm Hg) are given as mean7s.e.m., the number of rats is the same as
in Figure 2; þPo0.05 compared to Rf-1A, Rf-3, and Rf-1Aþ 3; *Po0.05
compared to ACI, Rf-1A, and Rf-3; 1Po0.05 compared to ACI and Rf-3;
#Po0.05 compared to Rf-1A and Rf-3.
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homozygous FHH (FF), while the Rf-1 genotype remains AA,
induced a slight increase in UPV per 100 g body weight (BW)
in all four treatments (Rf-3 effect). Similarly, changing the Rf-
1 genotype from AA to FF, while the Rf-3 genotype remains
AA, induced a small increase in UPV (Rf-1 effect). Assuming
an additive effect on UPV when Rf-1 and Rf-3 simultaneously
change from AA to FF, an expected change
in UPV can be calculated. In all situations, the observed
changes in UPV induced by changing both Rf-1 and Rf-3
from AA to FF significantly exceeded the expected calculated
change in UPV. The difference, being the interactive effect
of Rf-1 and Rf-3 depended on the experimental situation,
but was significant in all four situations. The magnitude of
the interaction was þ 5.971.7 mg/day/100 g BW in the 2 K
situation, þ 15.9711.8 mg/day/100 g BW with 2 Kþ L-
NAME, þ 20.777.2 mg/day/100 g BW following UNX, and
þ 50.0716.1 mg/day/100 g BW following UNXþ L-NAME.
Findings at end of experiment
BW, incidence of focal glomerulosclerosis (%FGS), and
creatinine clearance per 100 g BW (Cc/100) at the end of
the follow-up period are summarized in Table 2. Slight
difference in BW were noted, justifying the BW corrections
made with regard to UPV and creatinine clearance. The
%FGS was significantly higher in Rf-1Aþ 3 double congenic
rats compared to ACI rats, following 2Kþ L-NAME, UNX,
and UNXþ L-NAME treatment. Following UNXþ L-NAME,
the %FGS in Rf-1A and Rf-3 congenics was significantly
higher compared to the ACI control strain.
Table 1 | The effect of the Rf-1 and Rf-3 QTLs and their interaction on the development of UPV
6 weeks of
treatment
One-way
ANOVA P
2 2 factorial
ANOVA P
12 weeks of
treatment
Oneway
ANOVA P
2 2 factorial
ANOVA P
18 weeks of
treatment
Oneway
ANOVA P
2 2 factorial
ANOVA P
2K
Rf-3 effect +1.071.1 NS o0.001 +2.971.3 o0.05 o0.001 +1.471.0 o0.05 o0.001
Rf-1 effect 0.271.5 NS o0.001 0.271.2 NS o0.001 +0.671.2 NS o0.001
Interaction
of Rf-1 and
Rf-3
+5.171.7 N/A o0.001 +5.972.1 N/A o0.001 +6.271.9 N/A o0.001
2K+L-NAME
Rf-3 effect +1.072.0 NS 0.004 +2.872.1 NS 0.003 +6.873.4 o0.05 o0.001
Rf-1 effect +1.772.6 NS 0.002 +2.774.3 NS 0.004 +7.075.6 o0.05 o0.001
Interaction
of Rf-1 and
Rf-3
+8.775.9 N/A 0.013 +15.9711.8 N/A 0.028 +26.4716.5 N/A 0.008
UNX
Rf-3 effect +3.172.4 o0.05 o0.001 +2.472.6 NS o0.001 +2.472.9 NS o0.001
Rf-1 effect +3.873.5 o0.05 o0.001 +6.674.7 o0.05 o0.001 +11.775.2 o0.05 o0.001
Interaction
of Rf-1 and
Rf-3
+12.573.8 N/A o0.001 +20.777.2 N/A o0.001 16.677.8 N/A o0.001
UNX+L-NAME
Rf-3 effect +3.673.8 NS o0.001 +11.4710.1 0.003 o0.001 +20.2710.5 o0.001 0.002
Rf-1 effect +3.373.3 NS o0.001 +11.976.1 0.003 o0.001 +38.8716.8 o0.001 o0.001
Interaction
of Rf-1 and
Rf-3
+27.6711.9 N/A o0.001 +50.0716.1 N/A o0.001 +16.2717.3 N/A 0.038
For each treatment and time –point, the Rf-3 effect (UPVRf-3UPVACI), the Rf-1 effect (UPVRf-1AUPVACI), and the interaction (UPVRf-1A+3UPVRf-1AUPVRf-3+UPVACI) were
calculated. Data represent change in UPV (mg/day/100 g BW)7s.d. Statistical significance of Rf-1 and Rf-3 effects alone were calculated comparing the Rf-1 and Rf-3 strains
against the ACI controls by one-way ANOVA followed by the Bonferroni test. Statistical significance of the overall (main) effect of Rf-1 and Rf-3 and their interaction were
calculated using 2 2 factorial ANOVA.
2K, 2-kidneys; 2K+L-NAME, 2K+L-NAME-induced hypertension; UNX, unilateral nephrectomy; N/A: not applicable; NS: not significant; ANOVA, analysis of variance; BW=body
weight; UPV, proteinuria.
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Figure 4 | The effects of the Rf-1 and Rf-3 (chromosome 3)
genotype and the interaction between Rf-1 and Rf-3 on UPV after
12 weeks of treatment. (a) 2K. (b) 2Kþ L-NAME-induced hyperten-
sion. (c) Unilateral nephrectomy. (d) Unilateral nephrectomyþ L-
NAME-induced hypertension. Abbreviations are: AA, homozygous
ACI; FF, homozygous FHH. Values for UPV (mg/day/100 g BW) are
mean7s.e.m. Statistics are given in Table 1.
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In Rf-3 single congenic rats, Cc/100 was significantly higher
compared to ACI and Rf-1A single congenics in all treatment
groups. Following UNX, Rf-1Aþ 3 double congenics also
showed an increased Cc/100 compared to ACI and Rf-1A
single congenics.
Renal blood flow autoregulation
Autoregulation curves for the normalized renal blood flow
(RBF) (%RBF) are presented in Figure 5. From 110 to
150 mm Hg, mean %RBF values were significantly higher in
the Rf-1A single congenics compared to ACI rats. From 130
to 150 mm Hg, mean %RBF value of Rf-1Aþ 3 double
congenics were significantly higher compared to ACI rats.
This points to an impairment of the RBF autoregulation in
Rf-1A and Rf-1Aþ 3 rats. Over the pressure range
100–150 mm Hg, the renal autoregulatory index (RAI) was
0.2570.02 in ACI and 0.2870.03 in Rf-3 single congenics,
indicating a normal renal autoregulation in these strains. In
contrast, RAI values were significantly increased in Rf-1A
(0.5770.08) single and Rf-1Aþ 3 (0.4970.05) double
congenic rats, indicating an impaired renal autoregulation.
No marked renal damage was present in the rats used for
the autoregulation experiment. In all four strains, the average
UPV level was about 6–13 mg/day/100 g BW, while the
percentage of injured glomeruli was in the order of 2–6%.
This indicated that the impaired renal autoregulation is not
because of renal damage already acquired at the time of the
autoregulation studies.
DISCUSSION
The major finding of the present study is that introgressing
both the Rf-1 and Rf-3 QTLs on the ACI genomic
background have a powerful synergistic effect markedly
increasing susceptibility to renal damage. The synergistic
interaction between the Rf-1 and Rf-3 QTLs found in the Rf-
1Aþ 3 double congenic rat depends on the experimental
treatment and is quantitatively comparable with the syner-
gistic effect of Rf-1 and Rf-4 QTLs found earlier in Rf-1Aþ 4
double congenics.20 In previous studies, we found that rats
carrying the Rf-1 QTL had an impaired renal autoregula-
tion19,20 The Rf-1Aþ 3 double congenics also showed to have
an impaired renal autoregulation, similar to that of the Rf-1A
single congenic rat. In contrast, the Rf-3 single congenic has a
normal autoregulation, similar to that of the ACI rat. These
findings indicate that the Rf-3 region of the FHH rat does not
influence renal autoregulation.
In our original linkage analyses, Rf-1 and Rf-3 showed
significant LOD-scores for UPV, albuminuria, and FGS.
Furthermore, a synergistic interaction between Rf-1 and
other Rf regions was assumed.17 Our studies have now
provided direct evidence for a synergistic interaction between
the Rf-1 and Rf-3 QTLs. In contrast to the parental FHH
strain, the single and double congenics in the 2K control
group are normotensive, providing evidence that the Rf-1
and Rf-3 loci do not carry genes responsible for hypertension.
To detect changes in renal susceptibility resulting from the
introgression of the Rf-QTLs on the ACI background, we had
to raise systemic blood pressure. Based on our earlier
experience, we used chronic L-NAME treatment to raise
systemic blood pressure.21,22 As indicated in our previous
studies, using chronic L-NAME treatment has some dis-
Table 2 | Measurements obtained at end of follow-up
n BW (g)
FGS
(% glom.)
Cc/100 (ml/min/
100 g BW)
2K
ACI 12 30974 972 0.4670.03
Rf-3 12 31473 1372 0.7570.03a
Rf-1A 12 33377b 1472 0.5170.03
Rf-1A+3 12 31173 1472 0.5670.02
ANOVA P=0.002 P=0.251 Po0.001
2K+L-NAME
ACI 12 31975 1171 0.5070.02
Rf-3 12 32174 1872 0.7870.04a
Rf-1A 12 32873 2372 0.4970.01
Rf-1A+3 12 29676c 3176d 0.5270.04
ANOVA Po0.001 P=0.001 Po0.001
UNX
ACI 12 31573 1572 0.4170.01
Rf-3 12 31174 2072 0.6170.03e
Rf-1A 12 33076f 2373 0.4670.02
Rf-1A+3 12 30475 2773d 0.5870.02e
ANOVA P=0.002 P=0.014 Po0.001
UNX+L-NAME
ACI 12 31476 1571 0.4670.05
Rf-3 11 30176 3975d 0.6370.04a
Rf-1A 12 31976 3774d 0.4070.03
Rf-1A+3 5 263712c 64711c 0.3170.06
ANOVA Po0.001 Po0.001 Po0.001
2K, 2-kidneys; 2K+L-NAME, 2K+L-NAME-induced hypertension; UNX, unilateral
nephrectomy; BW, body weight (g); FGS, incidence of glomerulosclerosis (%
glomeruli); Cc/100, creatinine clearance (ml/min/100g BW). Values are given as
mean7s.e.m.; n is the number of rats; ANOVA, analysis of variance;
aPo0.05 compared to ACI, Rf-1A, and Rf-1A+3;
bPo0.05 compared to ACI and Rf-1A+3;
cPo0.05 compared to ACI, Rf-1A, and Rf-3;
dPo0.05 compared to ACI;
ePo0.005 compared to ACI and Rf-1A;
fPo0.05 compared to Rf-3 and Rf-1A+3.
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Figure 5 | Renal blood flow autoregulation curves in two-kidney
ACI (B, n¼ 21), Rf-1A (’, n¼ 12), Rf-3 ( , n¼ 15), and Rf-1Aþ 3
( , n¼ 16) rats. Values (as %RBF at RPP of 100 mm Hg) are given as
means7s.e.m. (error bars); %RBF, relative renal blood flow; RPP, renal
perfusion pressure; *Po0.05 vs ACI and Rf-3, 1Po0.05 vs ACI.
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advantages. It is difficult to match SBP between the various
strains at a level normally present in the FHH rat. Chronic
L-NAME treatment may directly affect the vascular structure
in the kidney, independent of its blood pressure effects.23
Furthermore, reducing endothelial nitric oxide synthase
activity by L-NAME may have a negative effect on the
protective action of nitric oxide in organs that are targets of
hypertensive injury.24 Thus, differences in renal damage
between Rf-1A, Rf-3 single congenics, and Rf-1Aþ 3 double
congenics and ACI rats may be partly because of an increased
susceptibility to L-NAME.
The simultaneous presence of two renal susceptibility
QTLs only marginally increases the level of UPV in the 2K
situation. An increased hemodynamic stress appears needed
to uncover the increased renal susceptibility even in
Rf1Aþ 3 or Rf1Aþ 4 double congenic rats. Loss of
functional renal mass is another way to increase hemo-
dynamic stress and induce progressive renal damage.25 There-
fore, we also tested if the renal susceptibility was increased
following UNX, while the rats remained normotensive. It
should be noted that in this situation the ACI was almost
completely protected from renal damage. Therefore, any
increase in renal damage present in the congenic rats must
be exclusively the result of FHH genomic regions introgressed
into the ACI genome. Following UNX, the Rf1Aþ 3 double
congenics showed by far the highest level of UPV. The level of
UPV being significantly higher than might be expected from
the effects of Rf-1 and Rf-3 alone. Thus, the Rf-3 QTL contains
one or more genes affecting the susceptibility to develop renal
damage after UNX. The direct effect of Rf-3 is small but in the
presence of an impaired renal autoregulation (Rf1?), Rf-3
markedly enhances renal susceptibility.
Together with our previously published studies, we now
have direct evidence that the Rf-1 and Rf-3 QTLs alone have
small effects on renal susceptibility, while the Rf-4 and Rf-5
by themselves have no effects at all.19,20 Furthermore, they
provided direct evidence for a synergistic interaction between
the Rf-1 and Rf-3 QTLs, as well as the Rf-1 and Rf-4 QTLs.
Interestingly, the magnitude of the interaction depended on
the experimental situation, that is, the presence or absence of
hypertension and/or reduced renal mass. Because of differ-
ences in SBP, a direct comparison of the renal susceptibility
between the double congenic strains and the FHH parental
strain is hard to make. It is clear that in the various
experimental situations the renal susceptibility of both the
Rf-1Aþ 3 and Rf-1Aþ 4 double congenic strains is less than
that of the parental FHH strain. This indicates that further
increases in renal susceptibility are to be expected when other
QTL combinations are tested. Renal autoregulation is
impaired to a similar extent in the Rf-1A single and the
Rf-1Aþ 3 or Rf-1Aþ 4 double congenic strains. Thus, it
seems likely that the effect of the Rf-1 QTL on renal
susceptibility is because of its effect on renal autoregulation.
The mechanism by which Rf-3 or Rf-4 enhance the effect of
Rf-1 remains unclear. It could be speculated that both Rf-3
and Rf-4 play a role in maintaining the integrity of the
glomerulus or the glomerular filtration barrier when exposed
to an increased hemodynamic stress. Further studies are
needed to clarify this.
An additional interesting finding was the presence of an
increased Cc/100 in the Rf-3 single congenic rats, suggesting
an increased glomerular filtration rate. The FHH parental
strain is characterized by the presence of glomerular
hyperfiltration, both at the whole kidney and the single
nephron level.10,26 Previous studies in 2K Rf-1, Rf-4, and Rf-5
single congenics did not show an increased Cc/100. Our
present findings in the Rf-3 single congenics would indicate
the presence of one or more genes in this region influencing
the glomerular filtration rate. However, an increased Cc/100
in the Rf-1Aþ 3 double congenics was only seen following
UNX and not in the 2K situation or 2 Kþ L-NAME-treated
rats. No good explanation is yet available for these differences
and further studies using better glomerular filtration rate
methodologies need to be performed.
With the completion of the sequencing of the human,
mouse, and rat genome, genomic comparisons between these
three species are greatly facilitated.27–30 The 95% confidence
interval of the rat Rf-3 region on chromosome 3 (RNO3:
117–146 Mb) is homologous to a part of human chromosome
20 (HSA20: 1–33 Mb) and mouse chromosome 2 (MMU2:
126–155 Mb) (http://www.ncbi.nlm.nih.gov/projects/Homol-
ogy/). Surprisingly, the Rf-3 homologous region in human
and mouse appear both to be involved in renal disease.
Linkage studies in Pima Indians suggest the presence of a
gene on chromosome 20 influencing diabetic nephropathy.31
The homologous region in the mouse has recently been
linked to albuminuria in KK/Ta mice.32 The presence of
QTLs linked to nephropathy in rat, mouse, and human make
the Rf-3 region very interesting for further investigation.
In conclusion, this study provides evidence that Rf-1 and
Rf-3 alone slightly increase the susceptibility to the develop-
ment of renal damage. However, a synergistic interaction
between these, the Rf-1 and Rf-3, QTLs does markedly
enhance renal susceptibility, especially in situations of
increased hemodynamic stress upon the kidney, that is,
hypertension or reduced renal mass.
MATERIALS AND METHODS
Congenic and control rat strains
For the experiments, male ACI.FHH-(D1Rat298-D1Rat90) (Rf-1A
for short), ACI.FHH-(D3Wox2-D3Rat59) (Rf-3 for short), and
ACI.FHH-(D1Rat475-D1Rat90)/(D3Rat84-D3Rat59) (Rf-1Aþ 3 for
short) congenic rats and ACI control rats were used. All breeding
was performed at the Animal Research Center at Erasmus MC,
Rotterdam, the Netherlands. Animals were housed in individually
ventilated cages under specific pathogen free (SPF)-conditions.33
The protocol received approval from the animal ethical committee
of the Erasmus University.
Congenic rat strains were generated using a speed congenic
strategy as described for the Rf-1B strain.18 As the single and double
congenic strains were generated in parallel, the size of the
introgressed congenic regions (homozygous for FHH) slightly
differs between the strains. A schematic view of the Rf regions of
1374 Kidney International (2006) 69, 1369–1376
o r i g i n a l a r t i c l e SJV Dijk et al.: Interaction between Rf-1 and Rf-3
the various congenic strains is presented in Figure 1. The
introgressed Rf-1 region in the double congenic rats is about
13 Mb shorter than in the single congenic. The introgressed Rf-3
region in the double congenic rats is about 7 Mb shorter than in the
single congenic. A whole genome scan with 150 genetic markers on
these three congenic strains showed that there was no FHH genomic
contamination on other chromosomes.
Renal damage susceptibility
Experiments for assessment of renal damage susceptibility were
performed on 184 animals starting from the age of 6 to 7 weeks. Per
strain, 48 animals were equally divided over four treatment groups.
The first received no specific treatment, but remained with 2K, and
was considered to be the control situation. The second consisted of
chronic oral treatment with L-NAME (Sigma-Aldrich Chemicals,
Zwijndrecht, the Netherlands) (2Kþ L-NAME) to induce systemic
hypertension. The third treatment consisted of UNX to reduce renal
mass, while the fourth was a combination of UNX and L-NAME
treatment (UNXþ L-NAME). Surgery for UNX and L-NAME
treatment were carried out as previously described.21
Urine of individual rats was collected after 6, 12, and 18 weeks of
treatment. The animals were housed in metabolic cages (Tecniplast,
Buggugiate, Italy). Urine was collected during 2 consecutive days
after a 3-day adaptation period. Following the urine collection, SBP
was measured at 3 consecutive days by the tail-cuff method, using a
photoelectric oscillatory detection device (IITC Life Science,
Woodland Hills, CA, USA) in awake, restrained rats, as described
previously.18
After the last series of urine collections and SBP measurements,
the rats were killed. Kidneys were weighed, and the left kidney was
used for histological examination. In a periodic-acid-Schiff-stained
slide, a total of 50 glomeruli were examined to determine the
incidence of %FGS as previously described.20
RBF autoregulation
Experiments for assessment of the RBF autoregulation were
performed on 64 animals (21 ACI, 12 Rf-1A, 15 Rf-3, and 16 Rf-
1Aþ 3 rats) at 13–15 weeks of age. To get an indication of the
presence of renal damage, UPV was assessed using a 24-h sample
obtained before the autoregulation experiments. After the evalua-
tion, the left kidney was used to determine the %FGS.
Animals were anaesthetized with a mixture of 3% Isofluranes,
30% N2O, and 60% O2 and surgically prepared for autoregulation
studies.14,15. After surgery and a 10-min equilibration period, the
relationship between the left kidney RBF and the renal perfusion
pressure was determined. The RBF was recorded as the renal
perfusion pressure was lowered from 150 to 80 mm Hg in 10 mm Hg
steps by tightening a clamp around the aorta, followed by a 3-min
equilibration period. To normalize the outcome of the individual
rats, the RBF at an renal perfusion pressure of 100 mm Hg (RBF100)
was considered to be 100%. RAIs over the range of pressures from
80 to 150 mm Hg were calculated by the method of Semple and de
Wardener.34 An RAI of 0 indicates perfect autoregulation of RBF,
and an RAI of 1 indicates that there is no autoregulation present
because of a fixed renal vascular resistance.
Analytical procedures
Plasma and urinary samples were analyzed with an ELAN system
(Eppendorf-Merck, Hamburg, Germany) using colorimetric assays.
Total urinary protein was determined colorimetrically with pyr-
ogallol red–molybdate complex.35 Plasma and urinary creatinine
levels were determined with the Jaffe´ method without deproteiniza-
tion.36
Statistics
Data are presented as mean7s.e.m. Statistical differences in mean
values between the groups were compared using one-way ANOVA.
In both studies, the ANOVA was followed by the Bonferroni test to
determine which pairs were significantly different. The experimental
design was also analyzed as a 2 2 factorial ANOVA providing an
evaluation of main effects and the interaction between the genotypes
of Rf-1 and Rf-3, being either homozygous ACI or homozygous
FHH. In all tests, a P-value o0.05 was considered statistically
significant.
One-way ANOVA, followed by Bonferroni test were performed
using the Primer of Biostatistics for Windows program (Version 4.0,
McGraw Hill, 1996). The 2 2 factorial ANOVA was performed
using a statistical program obtained at http://faculty.vassar.edu/
Lowry/anova2 2.html.
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